Streetbeat News

Earnings

CSCO

Recent analysis of Cisco Systems's (NASDAQ:CSCO) options market shows a bearish sentiment among whales, with 50% of trades being bearish and 40% bullish. The trades range between puts and calls, targeting a price range of $42.5 to $52.5. Notable trades include both bullish and bearish sweeps with varying strike prices and expiration dates. Cisco Systems, a leading networking equipment and software provider, is currently trading at $48.57, with an RSI indicating a neutral position. An earnings announcement is expected in 23 days.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 4:15 pm

HBAN

KRE

MCB

Regional bank stocks, represented by the SPDR S&P Regional Banking ETF (KRE), have rebounded from the 200-day moving average support, driven by strong Q1 2024 earnings reports. Despite the recovery, they remain nearly 20% below pre-March 2023 levels. Analysts highlight the sector's potential in a higher rate environment, with Metropolitan Bank (MCB) and Huntington Bancshares (HBAN) standing out for their performance and positive financial outlooks. MCB's shares surged 14% with a revised EPS estimate for 2024 and 2025, while HBAN's shares increased by over 6%, supported by solid first-quarter results.

Portfolio Pulse from Piero Cingari

April 22, 2024 | 4:10 pm

ACI

HEPA

MLEC

MTTR

NIVF

VAXX

WRNT

U.S. stocks traded higher with the Dow Jones, NASDAQ, and S&P 500 all seeing gains. Albertsons Companies Inc reported upbeat fourth-quarter earnings, while Matterport, Inc announced a significant acquisition deal by CoStar Group, causing its shares to spike. Other notable movements included Moolec Science SA and NewGenIvf Group Limited experiencing substantial share increases, whereas Vaxxinity, Inc, Hepion Pharmaceuticals, Inc, and Warrantee Inc faced sharp declines.

Portfolio Pulse from Avi Kapoor

April 22, 2024 | 4:07 pm

PRVA

Privia Health Gr (NASDAQ:PRVA) has received mixed analyst ratings over the last three months, with a recent shift towards more bullish perspectives. The average 12-month price target among analysts is $27.00, marking a 15.99% decline from the previous average. Analyst actions include both new ratings and adjustments to existing ones, with price targets ranging from $21.00 to $37.00. Privia Health is highlighted for its strong financial performance, including a notable revenue growth rate of 20.97%, a net margin of 0.64%, and efficient management reflected in its ROE and ROA figures. The company's low debt-to-equity ratio suggests a conservative financial strategy.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 4:00 pm

Alcoa Corp (NYSE:AA) reported first-quarter results with a slight revenue beat and is making progress in cost-saving measures. Morgan Stanley upgraded Alcoa's rating from Underweight to Equal-Weight and raised the price target from $28.50 to $36.50, citing solid progress in operational concerns and potential benefits from the Inflation Reduction Act. Shares of Alcoa rose by 0.25% to $35.61.

Portfolio Pulse from Priya Nigam

April 22, 2024 | 3:49 pm

SIFY

Sify Technologies Ltd (NASDAQ:SIFY) shares dropped after reporting Q4 sales of $116.05 million, missing the consensus of $149.30 million. Revenue growth was 8.8% Y/Y, with mixed performance across segments. Data Center services grew by 13.6%, Digital services fell by 8.7%, and Network services increased by 19.1%. EBITDA rose 11.4% to INR1.82 billion, and profit was INR38 million. The company expanded its infrastructure and workforce, focusing on Data Center presence and network interconnectivity. SIFY shares fell 4.88% to $1.17.

Portfolio Pulse from Anusuya Lahiri

April 22, 2024 | 3:48 pm

LCID

TSLA

Lucid Group, Inc. (NASDAQ:LCID) shares fell after Tesla, Inc. (NASDAQ:TSLA) and Li Auto, Inc. (NASDAQ:LI) announced new EV price cuts. Li Auto reduced prices by about 5% on several models, offering refunds to early buyers. Lucid recently shared details about the 2024 Lucid Air Grand Touring, boasting the longest range in the U.S. market. Citigroup gave Lucid a Neutral rating with a $2.90 price target. Lucid's Q1 financial results are expected to show losses of 26 cents per share with $155.986 million in revenue.

Portfolio Pulse from Erica Kollmann

April 22, 2024 | 3:32 pm

PFE

Financial analysis reveals a bullish sentiment in Pfizer's (NYSE:PFE) options trading, with 66% of trades being bullish. Significant activity includes 18 unusual trades, with a focus on calls over puts, indicating a target price range of $20.0 to $27.0. Pfizer's current market position is strong, with a recent price increase and an upcoming earnings announcement. Analyst ratings from Cantor Fitzgerald suggest a target price of $45, despite a downgrade to Overweight.

Portfolio Pulse from Benzinga Insights

April 22, 2024 | 3:31 pm

PEP

PepsiCo Inc (NASDAQ:PEP) is set to report its Q1 earnings on April 23, with Wall Street expecting $1.52 EPS and $18.12 billion in revenues. Despite a 5.73% decline over the past year, PEP's stock has risen 2.53% YTD and shows bullish signals with its price above key moving averages and positive technical indicators. However, analysts are cautious, with a consensus rating of Buy and a price target of $156.33, suggesting a potential downside.

Portfolio Pulse from Surbhi Jain

April 22, 2024 | 3:27 pm

MNDR

Mobile-Health Network's shares are trading lower following the company's issuance of its H1 2024 financial guidance.

Portfolio Pulse from Benzinga Newsdesk

April 22, 2024 | 3:27 pm